Winhealth Pharma

Patient comes first, always! We strive to build a patient-centric ecosystem
to provide accessibility and affordability to those in need.

Real
Impact for
the Rare ！

We search globally for breakthrough therapies
to transform lives!

Bringing hope and
solidarity to the patients
living under devastation
and solitude!

Learn more

Audaciously

Audaciously Committed to Building a
Healthier Community

Learn more

Rare Diseases

Urea Cycle Disorders (UCDs) - a Rare Disease which shall not be Ignored

UCDs sympton may occur at any age, depending on the severity of the disease. Some patientswith typical UCDs may present symptoms such as confusion, nausea, vomiting, decreased food intake or increased sleepiness within the first week after birth.

"Butterfly Baby"—— a Rare Disorder which is Often Misdiagnosed

"Butterfly Baby", the beautiful name undertakes unimaginable pain. Epidermolysis bullosa (EB) is a rare genetic skin disorder. Patient with EB is called Butterfly Baby as his/her skin is as fragile as butterfly wings.

Rare Disease Center

BO’AO WINHEALTH RARE DISEASE MEDICAL CENTER——Focuses on Rare Diseases and Provides Patients with Hope

BO’AO WINHEALTH RARE DISEASE MEDICAL CENTER is introducing the most advanced rare disease medical products into Chinese market at a pace synchronized with the world, bringing unprecedented hope to patients with rare disease in China and neighboring countries and regions.

Corporate Social Responsibility

Battling against Covid-19 Pandemics

As a biopharma organization, we believe that it's our essential responsibility to make meaningful contributions to the fight against Covid-19 Pandemics together with hundreds of generous Winhealthers. We have acted with speed and contributed to the battle against the Pandemics on multiple fronts.

Hong Kong Winhealth Pharma Group Co, Ltd donated CNY500,000 to support Wuhan

To ensure the drug supply chain operates, related communication and coordination work functions and emergencies can be timely handled during the Spring Festival. the company's leaders decided to urgently set up a 'temporary special emergency team' on January 24, 2020. In addition, a decision was made to donate CNY500, 000 to relevant medical institutions in Wuhan City through the Red Cross Society to fight against Covid-19.

Learn more

Corporate Social Responsibility

Project Rainbow

Winhealth has been supporting the "Project Rainbow" for 3 consecutive years and provides life supports to nearly 100 children. Their hope is our futures.

Adhering to the original intention of public welfare, Winhealth has paired with 70 underprivileged children.

The year 2020 is the final year of the fight against poverty and the building of a moderately prosperous society in all respects, and it is also the third year for Winhealth Pharma to participate in the public welfare education assistance action of "Project Rainbow". Committed to its original intention of public welfare, Winhealth Pharma has actively assumed its corporate social responsibility and worked hard on the path of poverty alleviation.

Learn more

Battling against Covid-19 Pandemics

Project Rainbow

News & Media

Accelerate Innovation Towards the Future,SAB of Winhealth Pharma Formally Established 2021-10-12

Winhealth-CARD Cooperation Boosts Rare Disease Healthy Ecosystem Construction 2021-10-09

Bo'ao Winhealth Rare Disease Medical Center and Ali Health Jointly Launched the "Global Drug Information Platform for Rare Diseases" 2021-09-27

Hainan Boao Lecheng International Medical Tourism Pilot Zone holds event to attract Japanese investment 2021-09-23

Good news! Glycerol Phenylbutyrate Oral Liquid (RAVICTI®) was Selected and Listed into the Catalog of Reference Listed Drug of the National Medical Products Administration! 2021-08-24

Dr. Meng Ling is appointed as Chief Medical Officer of Winhealth Pharma! 2021-08-16

Learn more

Relevant search

Company

Patients

Medicines

Business

News & Media

Careers

Contact Us